The UAE artificial organs & bionic implants market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing accidents and road injuries and the rising incidence of disabilities and organ failure. Furthermore, the technological advancements and the increasing healthcare expenditure in the region are boosting the market growth.
Artificial organs and bionics refers to man-made devices that can be integrated or implanted into humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to sustain a normal life.
As per Dubai Health Authority (DHA), 2019, UAE has high prevalence of diabetes; the prevalence of diabetes is anticipated to rise to more than 21.5%. The key factors responsible for the amputations are due to diabetic foot ulcers. More than half of all foot ulcers (wounds) are expected to become infected, requiring hospitalization, and 20% of infections were expected to result in amputation.
The Covid-19 pandemic had a positive impact on the UAE artificial organs & bionic implants market. According to World Health Organisation (WHO) the Covid-19 pandemic has impacted and surged the demand artificial organs & bionic implants. It has generated immense opportunity for the market. Also government’s support in developing such technologies is expected to boost the global market of UAE artificial organs & bionic implants.
The report on the UAE artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
UAE Artificial Organs & Bionic Implants Market –Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Product (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, and Others]) |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation. |
Based on product, the artificial organs & bionic implants market is segregated into artificial organs, bionics. The artificial organ segment is further divided into artificial heart, artificial kidney, cochlear implants, and others and the bionics segment is further divided into vision bionics, ear bionics, orthopedic bionic, cardiac bionics, and others. The orthopedic bionic segment is expected to account for a key share of the market during the forecast period owing to increasing prevalence of road accidents and injuries, which is increasing the demand for artificial limbs and other bionics. Furthermore, increasing geriatric population who are in need of total joints replacement and knee replacement is also fueling the segment growth.
Segments Covered in the Report
The UAE artificial organs & bionic implants market has been segmented on the basis of:-
Product
Key Companies
Key players competing in the UAE artificial organs & bionic implants market include Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Some other reports from this category!